Search research articles
Contact Us
Filters
Showing results (141-150 of 166) with videos related to
Page
of 17
Sort By:
Journal of Cell Science
|
February 10, 2023
DRP1 mutations associated with EMPF1 encephalopathy alter mitochondrial membrane potential and metabolic programs
Gabriella L Robertson, Stellan Riffle, Mira Patel, et al.
Protein Science : a Publication of the Protein Society
|
December 3, 2005
Structure of MurF from Streptococcus pneumoniae co-crystallized with a small molecule inhibitor exhibits interdomain closure
Kenton L Longenecker, Geoffrey F Stamper, Philip J Hajduk, et al.
Journal of Medicinal Chemistry
|
October 22, 2009
Discovery of 3H-benzo[4,5]thieno[3,2-d]pyrimidin-4-ones as potent, highly selective, and orally bioavailable inhibitors of the human protooncogene proviral insertion site in moloney murine leukemia virus (PIM) kinases
Zhi-Fu Tao, Lisa A Hasvold, Joel D Leverson, et al.
Chembiochem : a European Journal of Chemical Biology
|
January 10, 2018
Design of Aminobenzothiazole Inhibitors of Rho Kinases 1 and 2 by Using Protein Kinase A as a Structure Surrogate
Russell A Judge, Anil Vasudevan, Victoria E Scott, et al.
Journal of Medicinal Chemistry
|
January 23, 2004
Design, synthesis, and biological activity of 4-[(4-cyano-2-arylbenzyloxy)-(3-methyl-3H-imidazol-4-yl)methyl]benzonitriles as potent and selective farnesyltransferase inhibitors
Le Wang, Gary T Wang, Xilu Wang, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 15, 2011
Hepatitis C NS5B polymerase inhibitors: functional equivalents for the benzothiadiazine moiety
Douglas K Hutchinson, Charles A Flentge, Pamela L Donner, et al.
Chemical Biology & Drug Design
|
February 24, 2006
Structure-based optimization of MurF inhibitors
Geoffrey F Stamper, Kenton L Longenecker, Elizabeth H Fry, et al.
Journal of Computer-Aided Molecular Design
|
February 13, 2007
Design and characterization of an engineered gp41 protein from human immunodeficiency virus-1 as a tool for drug discovery
Kent D Stewart, Kevin Steffy, Kevin Harris, et al.
Biochemistry
|
June 14, 2006
Crystal structures of DPP-IV (CD26) from rat kidney exhibit flexible accommodation of peptidase-selective inhibitors
Kenton L Longenecker, Kent D Stewart, David J Madar, et al.
Global Food Security
|
September 13, 2021
Emerging COVID-19 impacts, responses, and lessons for building resilience in the seafood system
David C Love, Edward H Allison, Frank Asche, et al.
Page
of 17
Search research articles
Search
Showing results (141-150 of 166) with videos related to
Sort By:
Page
of 17
Journal of Cell Science
|
February 10, 2023
DRP1 mutations associated with EMPF1 encephalopathy alter mitochondrial membrane potential and metabolic programs
Gabriella L Robertson, Stellan Riffle, Mira Patel, et al.
Protein Science : a Publication of the Protein Society
|
December 3, 2005
Structure of MurF from Streptococcus pneumoniae co-crystallized with a small molecule inhibitor exhibits interdomain closure
Kenton L Longenecker, Geoffrey F Stamper, Philip J Hajduk, et al.
Journal of Medicinal Chemistry
|
October 22, 2009
Discovery of 3H-benzo[4,5]thieno[3,2-d]pyrimidin-4-ones as potent, highly selective, and orally bioavailable inhibitors of the human protooncogene proviral insertion site in moloney murine leukemia virus (PIM) kinases
Zhi-Fu Tao, Lisa A Hasvold, Joel D Leverson, et al.
Chembiochem : a European Journal of Chemical Biology
|
January 10, 2018
Design of Aminobenzothiazole Inhibitors of Rho Kinases 1 and 2 by Using Protein Kinase A as a Structure Surrogate
Russell A Judge, Anil Vasudevan, Victoria E Scott, et al.
Journal of Medicinal Chemistry
|
January 23, 2004
Design, synthesis, and biological activity of 4-[(4-cyano-2-arylbenzyloxy)-(3-methyl-3H-imidazol-4-yl)methyl]benzonitriles as potent and selective farnesyltransferase inhibitors
Le Wang, Gary T Wang, Xilu Wang, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 15, 2011
Hepatitis C NS5B polymerase inhibitors: functional equivalents for the benzothiadiazine moiety
Douglas K Hutchinson, Charles A Flentge, Pamela L Donner, et al.
Chemical Biology & Drug Design
|
February 24, 2006
Structure-based optimization of MurF inhibitors
Geoffrey F Stamper, Kenton L Longenecker, Elizabeth H Fry, et al.
Journal of Computer-Aided Molecular Design
|
February 13, 2007
Design and characterization of an engineered gp41 protein from human immunodeficiency virus-1 as a tool for drug discovery
Kent D Stewart, Kevin Steffy, Kevin Harris, et al.
Biochemistry
|
June 14, 2006
Crystal structures of DPP-IV (CD26) from rat kidney exhibit flexible accommodation of peptidase-selective inhibitors
Kenton L Longenecker, Kent D Stewart, David J Madar, et al.
Global Food Security
|
September 13, 2021
Emerging COVID-19 impacts, responses, and lessons for building resilience in the seafood system
David C Love, Edward H Allison, Frank Asche, et al.
Page
of 17